Sustainability in Orthopaedic Product Manufacturing

Sustainability in Orthopaedic Product Manufacturing

Sustainability has become a critical consideration across healthcare, and orthopaedic product manufacturing is no exception. As the demand for implants, plates, screws, and prostheses rises, driven by an ageing population, increased trauma cases, and advances in surgical techniques, the environmental footprint of these products warrants close attention. Orthopaedic manufacturing involves resource-intensive processes: sourcing raw materials like titanium and stainless steel, precision machining, sterilisation, packaging, and global distribution. These steps contribute to carbon emissions, waste generation, and resource depletion. 

In the UK, the NHS has committed to net-zero carbon emissions by 2040, with an interim target of an 80% reduction by 2028–2032. Orthopaedic surgery, a high-resource specialty, plays a significant role in this transition. The British Orthopaedic Association (BOA) promotes sustainability in orthopaedics through guidance, education, and advocacy. While sustainability is increasingly recognised in clinical practice and training, specific requirements within formal curricula vary. Manufacturers and distributors influence environmental impacts upstream through material choices, production methods, and supply chain practices. 

At Leda Orthopaedics, a specialist UK distributor established in 2013, we focus on innovative upper limb trauma solutions through partnerships with manufacturers such as Skeletal Dynamics,  Orthopaedics, and Groupe Lépine. While our primary role is distribution, we recognise our responsibility in Toby supporting sustainable healthcare. Our 2024 Carbon Footprint Report demonstrates commitment to accurate emissions accounting under GHG Protocol standards, focusing on Scope 1, 2, and relevant Scope 3 categories such as purchased goods and services. Certain downstream emissions, including product end-of-life or use-phase energy, are excluded where influence is limited, but supplier collaboration is prioritised to enhance environmental performance. As data quality improves, future reports will expand coverage to include waste and downstream impacts.  

The Environmental Challenges in Orthopaedic Manufacturing

Orthopaedic implants are predominantly made from metals; titanium alloys, cobalt-chrome, and stainless steel; due to their strength, biocompatibility, and durability, essential for load-bearing applications like proximal humerus plates or radial head replacements. Manufacturing these involves energy-intensive processes: mining/extraction of ores, smelting, forging, CNC machining, surface treatments (e.g., anodising or porous coating), and sterilisation (often gamma irradiation or ethylene oxide). 

Lifecycle analyses show that manufacturing contributes substantially to an implant’s carbon footprint, alongside packaging and transportation. Single-use instruments and extensive sterile packaging generate significant waste; studies suggest orthopaedic procedures produce notable volumes of recyclable and hazardous waste, highlighting opportunities for improved segregation and recycling. Implant manufacturing contributes to this footprint through material extraction and production emissions. 

In trauma orthopaedics, products like locking plates, intramedullary devices, or joint prostheses often use permanent implants. While these provide reliable long-term function, their production and disposal raise sustainability concerns. Metal recycling programmes can recover valuable materials from explanted or unused implants, though implementation varies across hospitals and regions. 

Key Areas for Improvement

Several strategies are emerging to make orthopaedic product manufacturing more sustainable: 

Material Innovation and Alternatives

Permanent metallic implants dominate due to mechanical strength, but bioresorbable options, such as magnesium alloys and polylactic acid-based polymers, offer promise for certain applications. These materials degrade naturally in the body, potentially reducing revision surgery and long-term environmental burden from disposal. While currently limited to lower-load scenarios (e.g., some hand/wrist fixation), research aims to improve strength for broader use. 3D printing with bioresorbable materials also enables patient-specific designs, reducing waste through additive manufacturing’s efficiency compared to traditional subtractive methods. 

Additive Manufacturing (3D Printing)

Additive techniques produce less waste than forging or casting, support on-demand production, and facilitate complex geometries with minimal material. When powered by renewable energy and using sustainable biomaterials, 3D printing aligns with circular economy principles: reduce, reuse, recycle. Patient-matched implants minimise overproduction and excess inventory. 

Packaging and Supply Chain Optimisation

Excessive packaging for sterility contributes to waste. Manufacturers are reducing plastic use, opting for recyclable materials, or redesigning trays for reusability. Efficient logistics, local sourcing where feasible, and consolidated shipments lower transport emissions. 

Reusable vs Single-Use Instruments

While many trauma sets remain single-use for infection control, reusable instrument systems can cut energy and waste in some cases. Hybrid approaches balance safety with sustainability. 

Circular Economy Approaches

Recycling explanted medical implants allows for the recovery of metals, reducing virgin material demand. Closed-loop systems could reprocess materials into new implants, although regulatory and quality requirements pose challenges. 

UK-specific drivers include BOA (The British Orthopaedic Association) initiatives for greener surgery, NHS sustainable procurement frameworks, and growing attention to environmental aspects within Medical Device Regulation (MDR) considerations. Distributors like Leda play a role by selecting partners with strong sustainability credentials and educating clinicians on eco-conscious choices. 

Leda Orthopaedics’ Contribution to Sustainability

As a UK-based distributor specialising in upper limb trauma, Leda Orthopaedics supports sustainable practices indirectly through high-quality, durable products that aim to reduce revision rates and associated resource use. Our portfolio includes: 

These innovations focus on precision and longevity, aligning with sustainability by optimising outcomes and potentially reducing downstream healthcare resource consumption. We collaborate with partners to provide clinical education, workshops, and feedback to refine products. Our carbon reporting underscores transparency, and we continue working with suppliers to improve environmental performance. 

Looking Ahead

The future of orthopaedic product manufacturing lies in integrating sustainability without compromising patient safety or clinical efficiency. Advances in biodegradable implants, smart monitoring technologies, and circular models will drive progress. Alignment with NHS net-zero goals, BOA guidance, and evolving regulatory expectations will support adoption. 

Challenges remain in balancing biocompatibility with eco-materials, ensuring regulatory compliance for novel processes, and managing cost implications. However, innovation, collaboration, and conscious procurement offer numerous opportunities. 

At Leda Orthopaedics, we remain committed to delivering advanced trauma solutions that support excellent clinical care while contributing to a more sustainable orthopaedic ecosystem. By partnering with forward-thinking manufacturers and engaging with the UK orthopaedic community, we aim to play our part in greening the specialty. For more on our products or sustainability efforts, visit ledaortho.com. 

© 2026 LEDA. All rights reserved. Designed by Deliver